News Coverage 07.23.19 By: Amber Tong Share on Twitter Share on Facebook Share on LinkedIn PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Related Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research